/Companies

Weed

OTC: BUDZ

Tucson, US · Nevada corporation · 2 known investors

Find your way into Weed

Each arrow is one introduction. Sign up to fill in the first one.

48 people can intro you to Nicole

Ask Jon Volk to introduce you to Nicole M Breen

You →Jon · together at University of Arizona →Nicole

Sign up to find every way you can get introduced to Weed

  • Your email: who you already know at Weed, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Weed team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

A bio-pharmaceutical and real estate holding company that conducts cannabis genomic research through its subsidiaries to develop improved cannabis and hemp strains for medical and industrial applications, while maintaining agricultural licenses and significant real estate holdings.

Founders & leadership

GE
Glenn E MartinDirector and Chief Executive Officer
NMNicole M Breen
Nicole M BreenDirector, Secretary and TreasurerNicole M Breen is Director, Secretary, and Treasurer of WEED, Inc., a bio-pharmaceutical and real estate holding company conducting cannabis genomic research, and also serves in the same roles at HEMP BioSciences Inc., a subsidiary, since January 2021.
PE
Patrick E WilliamsNamed on SEC filing

Investors · 2

Reported raises · per SEC filings

Form D private placements

$11.6M disclosed across 1 round · 2018

▶$11.6MraisedFeb 2018 · 2 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Patrick E WilliamsDirector
  • Glenn E MartinExecutive Officer, Director
  • Nicole M BreenExecutive Officer, Director
Offering amount
$11.6M
Amount sold
$11.6M
First sale
Feb 2018
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Valuation · disclosed

Disclosed events
$101.2Mvaluation at IPOJul 2018 · $1.00/share · S-1/A
filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

Frequently asked questions

What does Weed do?
A bio-pharmaceutical and real estate holding company that conducts cannabis genomic research through its subsidiaries to develop improved cannabis and hemp strains for medical and industrial applications, while maintaining agricultural licenses and significant real estate holdings.
Who founded Weed?
Weed was founded by Glenn E Martin.
Who are Weed's investors?
Weed's investors include Clay Capital, Fulcrum Global Capital.
How much funding has Weed raised?
Weed has disclosed $11.6M raised across 1 round.
Where is Weed headquartered?
Weed is headquartered in Tucson, US.